Global Health Ltd
NSE:MEDANTA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (45.1), the stock would be worth ₹1 157.27 (5% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 42.9 | ₹1 101.5 |
0%
|
| 3-Year Average | 45.1 | ₹1 157.27 |
+5%
|
| 5-Year Average | 44.9 | ₹1 154.08 |
+5%
|
| Industry Average | 42.5 | ₹1 092.23 |
-1%
|
| Country Average | 23.3 | ₹597.47 |
-46%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
₹304.9B
|
/ |
Jan 2026
₹6.8B
|
= |
|
|
₹304.9B
|
/ |
Mar 2026
₹7.2B
|
= |
|
|
₹304.9B
|
/ |
Mar 2027
₹9.7B
|
= |
|
|
₹304.9B
|
/ |
Mar 2028
₹11.6B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
G
|
Global Health Ltd
NSE:MEDANTA
|
298.6B INR | 42.9 | 57.6 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
98.7B USD | 11.5 | 14.5 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 40 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.8B ZAR | 9.4 | 14.2 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
78.2B MYR | 22.9 | 37.2 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.8B ZAR | -52.9 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
83.5B BRL | 9.1 | 17.9 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.7B USD | 6.8 | 11.2 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
97.1B CNY | 20.5 | 28.8 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 43.1 | 61.6 | |
| US |
|
Universal Health Services Inc
NYSE:UHS
|
10.6B USD | 7.3 | 7.2 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 15.7 |
| Median | 23.3 |
| 70th Percentile | 34.7 |
| Max | 48 145.1 |
Other Multiples
Global Health Ltd
Glance View
Global Health Ltd., a growing name in the healthcare sector, has carved out a niche in advancing modern medical practices across a range of facilities. With a network of multi-specialty hospitals, the company has positioned itself as a formidable provider of comprehensive healthcare solutions. These hospitals span numerous locations, utilizing cutting-edge technology and highly skilled medical professionals to offer services that range from routine wellness care to specialized treatments. Global Health Ltd.'s holistic approach ensures not only treatment of diseases but also focuses on preventive measures and long-term health improvement. This emphasis on varied healthcare services allows the company to reach a broad audience, contributing to its steady revenue stream. Revenue generation for Global Health Ltd. primarily stems from patient fees, which include costs for inpatient and outpatient services, diagnostics, surgical procedures, and other medical services. Additionally, the company leverages partnerships with insurance providers, ensuring a wider reach and facilitating payments through insurance claims. By maintaining strategic alliances and continuously upgrading its healthcare offerings, Global Health Ltd. amplifies its market presence. Through innovation and an unwavering commitment to quality care, the company not only bolsters its financial strength but also enhances its reputation as a leader in the healthcare industry, adeptly navigating the ever-evolving demands of the sector.
